OSCR
Oscar Health, Inc.
$28.26
-2.25%
$8.5B
No data for this timeframe.
Vol
Market Cap$8.5B
Cap SizeMid Cap
Analyst ConsensusHold (42%)
Inst. Holders50 funds
Inst. Value$1.3B
Inst. Activity20 buys / 16 sells
Insider Activity1B / 7S
Insider Net $$5.7M
Reddit Sentiment63° Warm
SEC Reports8
Recent Activity
Jun 11, 2026
SEC
In Q4 2025, seven institutional investors accumulated a net $189.7M in Oscar Health (OSCR), led by quant funds D.E. Shaw
INST-CLUSTER — Impact 7/10
Jun 8, 2026
SEC
Five Oscar Health insiders, including the CFO, President of Oscar Insurance, and Chief Legal Officer, sold a total of ~$
CLUSTER — Impact 2/10
Jun 8, 2026
SEC
Oscar Health filed an 8-K announcing its participation in a fireside chat at the Goldman Sachs 47th Annual Global Health
8-K — Impact 3/10
Jun 4, 2026
Insider
Plouffe David was granted 8,475 shares
Director
Jun 4, 2026
Insider
Sankaran Sid was granted 8,475 shares
Director
Jun 4, 2026
Insider
Gassen William was granted 8,475 shares
Director
Inst.
MORGAN STANLEY — TRIM
3,354,981 shares ($38.5M)
Inst.
BANK OF AMERICA CORP — DOUBLED
2,860,310 shares ($32.8M)
Price Targets
$22.60
-20.0% upside
Strong Sell
Current $28.26
Low $13.00
Median $21.00
High $35.00
10 analysts
$13.00
$35.00
Analyst Ratings
2Strong Buy
6Buy
9Hold
2Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 10, 2026 | Barclays | UPGRADE | Equal-Weight → Overweight |
| May 26, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| May 7, 2026 | UBS | MAINTAIN | Neutral → Neutral |
| May 7, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| May 7, 2026 | Baird | MAINTAIN | Neutral → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.33 ▼ -16.0% | $-0.18 — $0.69 | 137% YoY | 10 |
| Next Q | $-0.19 ▲ +1.6% | $-0.46 — $0.00 | 64% YoY | 10 |
| Current FY | $1.07 ▲ +10.8% | $0.63 — $1.38 | 163% YoY | 9 |
| Next FY | $1.46 ▲ +5.8% | $1.00 — $2.00 | 36% YoY | 10 |
Latest Reports
BULLISH
INST-CLUSTER
7/10
In Q4 2025, seven institutional investors accumulated a net $189.7M in Oscar Health (OSCR), led by quant funds D.E. Shaw
Jun 11, 2026
NEUTRAL
CLUSTER
2/10
Five Oscar Health insiders, including the CFO, President of Oscar Insurance, and Chief Legal Officer, sold a total of ~$
Jun 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $198.5M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $123.6M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $121.0M | — |
| D. E. Shaw & | $62.9M | DOUBLED |
| STATE STREET CORP | $60.4M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | Plouffe David | A | $0.00 |
| Jun 4, 2026 | Sankaran Sid | A | $0.00 |
| Jun 4, 2026 | Gassen William | A | $0.00 |
| Jun 4, 2026 | Lang Laura | A | $0.00 |
| Jun 4, 2026 | WITTMAN VANESSA | A | $0.00 |
Reddit Sentiment
63°
Warm
Bearish
Neutral
Bullish
50 institutional holders with $1.3B total value (111,890,509 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 20 institutions added/increased vs 16 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 17,309,539 | $198.5M | 15.5% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 10,777,627 | $123.6M | 9.6% | — |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 10,545,848 | $121.0M | 9.4% | — |
| 4 | D. E. Shaw & Co., Inc. | 5,485,285 | $62.9M | 4.9% | DOUBLED +283.6% |
| 5 | STATE STREET CORP | 5,262,372 | $60.4M | 4.7% | — |
| 6 | DIMENSIONAL FUND ADVISORS LP | 4,192,777 | $48.1M | 3.7% | — |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3,482,700 | $39.9M | 3.1% | — |
| 8 | CITADEL ADVISORS LLC | 3,466,362 | $39.8M | 3.1% | — |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3,424,100 | $39.3M | 3.1% | — |
| 10 | MORGAN STANLEY | 3,354,981 | $38.5M | 3.0% | TRIM -50.8% |
| 11 | Point72 Asset Management, L.P. | 3,113,671 | $35.7M | 2.8% | DOUBLED +569.4% |
| 12 | BANK OF AMERICA CORP /DE/ | 2,860,310 | $32.8M | 2.6% | DOUBLED +205.1% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,745,804 | $31.5M | 2.5% | — |
| 14 | TWO SIGMA INVESTMENTS, LP | 2,349,525 | $26.9M | 2.1% | DOUBLED +1415.2% |
| 15 | WOLVERINE ASSET MANAGEMENT LLC | 2,342,800 | $26.9M | 2.1% | — |
| 16 | CITADEL ADVISORS LLC | 2,171,800 | $24.9M | 1.9% | — |
| 17 | CITADEL ADVISORS LLC | 2,154,200 | $24.7M | 1.9% | — |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,898,745 | $21.8M | 1.7% | — |
| 19 | TUDOR INVESTMENT CORP ET AL | 1,720,794 | $19.7M | 1.5% | — |
| 20 | Freestone Grove Partners LP | 1,602,569 | $18.4M | 1.4% | DOUBLED +214.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 6,814,046 | 3,354,981 | -50.8% | $38.5M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 937,578 | 2,860,310 | +205.1% | $32.8M | 2026-Q1 |
| Freestone Grove Partners LP | DOUBLED | 508,936 | 1,602,569 | +214.9% | $18.4M | 2026-Q1 |
| JUPITER ASSET MANAGEMENT LTD | NEW | — | 1,333,869 | — | $15.3M | 2026-Q1 |
| GROUP ONE TRADING LLC | ADD | 673,660 | 1,257,777 | +86.7% | $14.4M | 2026-Q1 |
| Assenagon Asset Management S.A. | ADD | 640,760 | 1,227,803 | +91.6% | $14.1M | 2026-Q1 |
| FMR LLC | TRIM | 1,928,912 | 1,198,772 | -37.9% | $13.7M | 2026-Q1 |
| Trexquant Investment LP | DOUBLED | 295,998 | 1,018,333 | +244.0% | $11.7M | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | DOUBLED | 136,100 | 754,700 | +454.5% | $8.7M | 2026-Q1 |
| VICTORY CAPITAL MANAGEMENT INC | DOUBLED | 24,248 | 526,699 | +2072.1% | $6.0M | 2026-Q1 |
| SEI INVESTMENTS CO | DOUBLED | 50,288 | 400,149 | +695.7% | $4.6M | 2026-Q1 |
| Russell Investments Group, Ltd. | ADD | 211,385 | 353,603 | +67.3% | $4.1M | 2026-Q1 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | ADD | 237,882 | 318,532 | +33.9% | $3.7M | 2026-Q1 |
| VOYA INVESTMENT MANAGEMENT LLC | DOUBLED | 35,601 | 197,317 | +454.2% | $2.3M | 2026-Q1 |
| TD ASSET MANAGEMENT INC | ADD | 133,168 | 195,464 | +46.8% | $2.2M | 2026-Q1 |
| ExodusPoint Capital Management, LP | TRIM | 343,571 | 165,533 | -51.8% | $1.9M | 2026-Q1 |
| Clear Street Group Inc. | TRIM | 260,345 | 150,210 | -42.3% | $1.7M | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | ADD | 60,335 | 80,050 | +32.7% | $918.2K | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | NEAR_EXIT | 342,282 | 60,295 | -82.4% | $691.6K | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | DOUBLED | 13,719 | 50,707 | +269.6% | $581.6K | 2026-Q1 |
| Brevan Howard Capital Management LP | TRIM | 90,523 | 47,092 | -48.0% | $540.1K | 2026-Q1 |
| HighTower Advisors, LLC | TRIM | 54,154 | 36,678 | -32.3% | $420.7K | 2026-Q1 |
| XPONANCE LLC | ADD | 15,872 | 21,780 | +37.2% | $249.8K | 2026-Q1 |
| STATE OF WISCONSIN INVESTMENT BOARD | ADD | 14,290 | 19,622 | +37.3% | $225.1K | 2026-Q1 |
| Wealthfront Advisers LLC | TRIM | 31,108 | 17,018 | -45.3% | $195.2K | 2026-Q1 |
12 unique insiders with 26 transactions. Net insider value: $5.7M ($11.9M bought, $6.3M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Plouffe David | Director | AWARD | 8,475 | — | — |
| Jun 4, 2026 | Sankaran Sid | Director | AWARD | 8,475 | — | — |
| Jun 4, 2026 | Gassen William | Director | AWARD | 8,475 | — | — |
| Jun 4, 2026 | Lang Laura W | Director | AWARD | 8,475 | — | — |
| Jun 4, 2026 | WITTMAN VANESSA AMES | Director | AWARD | 8,475 | — | — |
| Jun 2, 2026 | Schlosser Mario | Director | SELL | 24,452 | $21.74 | $531.6K |
| Jun 2, 2026 | Baltrus Victoria | Chief Accounting Officer | SELL | 1,091 | $21.74 | $23.7K |
| Jun 2, 2026 | Blackley Richard Scott | Chief Financial Officer | SELL | 22,706 | $21.74 | $493.6K |
| Jun 2, 2026 | Liang Janet | President, Oscar Insurance | SELL | 8,940 | $21.74 | $194.4K |
| Jun 2, 2026 | McAnaney Adam | Chief Legal Officer | SELL | 7,065 | $21.74 | $153.6K |
| May 18, 2026 | Blackley Richard Scott | Chief Financial Officer | SELL | 110,000 | $25.03 | $2.8M |
| May 14, 2026 | Blackley Richard Scott | Chief Financial Officer | SELL | 91,259 | $23.10 | $2.1M |
| Apr 9, 2026 | Gassen William | Director | AWARD | 1,418 | $14.54 | $20.6K |
| Apr 9, 2026 | Plouffe David | Director | AWARD | 1,461 | $14.54 | $21.2K |
| Apr 9, 2026 | BOYD JEFFERY H | Director | AWARD | 3,610 | $14.54 | $52.5K |
| Apr 9, 2026 | Sankaran Sid | Director | AWARD | 1,203 | $14.54 | $17.5K |
| Apr 6, 2026 | Bertolini Mark T | Chief Executive Officer | TAX W/H | 1,000,001 | $11.92 | $11.9M |
| Apr 6, 2026 | Bertolini Mark T | Chief Executive Officer | BUY | 1,000,000 | $11.92 | $11.9M |
| Apr 3, 2026 | Bertolini Mark T | Chief Executive Officer | EXERCISE | 5,733,334 | — | — |
| Mar 12, 2026 | Blackley Richard Scott | Chief Financial Officer | GIFT | 75,000 | — | — |
| Mar 2, 2026 | Liang Janet | President, Oscar Insurance | AWARD | 106,458 | — | — |
| Mar 2, 2026 | Bertolini Mark T | Chief Executive Officer | AWARD | 1,596,877 | — | — |
| Mar 2, 2026 | Baltrus Victoria | Chief Accounting Officer | AWARD | 17,300 | — | — |
| Mar 2, 2026 | McAnaney Adam | Chief Legal Officer | AWARD | 67,424 | — | — |
| Mar 2, 2026 | Schlosser Mario | President of Technology & CTO | AWARD | 189,141 | — | — |
| Mar 2, 2026 | Blackley Richard Scott | Chief Financial Officer | AWARD | 134,847 | — | — |
8 SEC filing reports analyzed. Sentiment: 2 bullish, 1 bearish, 0 mixed, 5 neutral. Avg impact: 4.1/10.
BULLISH
INST-CLUSTER
7/10
In Q4 2025, seven institutional investors accumulated a net $189.7M in Oscar Health (OSCR), led by q
Jun 11, 2026
NEUTRAL
CLUSTER
2/10
Five Oscar Health insiders, including the CFO, President of Oscar Insurance, and Chief Legal Officer
Jun 8, 2026
NEUTRAL
8-K
3/10
Oscar Health filed an 8-K announcing its participation in a fireside chat at the Goldman Sachs 47th
Jun 8, 2026
BEARISH
144
4/10
Oscar Health CFO Richard Scott Blackley filed a Form 144 on June 2, 2026, indicating intent to sell
Jun 2, 2026
NEUTRAL
8-K
2/10
Oscar Health filed an 8-K reporting that co-founder Mario Schlosser transitioned from President of T
Jun 2, 2026
NEUTRAL
144
3/10
Oscar Health CFO Richard Scott Blackley filed a Form 144 indicating intent to sell 100,000 common sh
May 14, 2026
BULLISH
8-K
8/10
Oscar Health reported Q1 2026 total revenue of $4.65B (up 52.6% YoY) and diluted EPS of $2.07, signi
May 6, 2026
NEUTRAL
8-K
4/10
Oscar Health reaffirmed its full-year 2026 guidance ahead of the Medicarians 2026 conference and ann
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Hold (42% buy). Based on 19 analysts: 2 strong buy, 6 buy, 9 hold, 2 sell, 0 strong sell.
Analyst Price Targets
$22.60 mean target
-20.0% upside
Strong Sell (2.82)
$13.00 Low
$35.00 High
| Metric | Value |
|---|---|
| Current Price | $28.26 |
| Target Low | $13.00 |
| Target Mean | $22.60 |
| Target Median | $21.00 |
| Target High | $35.00 |
| # Analysts | 10 |
| Recommendation | Strong Sell (2.82) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.33 | $-0.18 | $0.69 | 137.4% | -16.0% | 4↑ 2↓ | $4.7B | 65.6% | 10 |
| Next Q 2026-09-30 |
$-0.19 | $-0.46 | $0.00 | 64.1% | +1.6% | 1↑ 5↓ | $4.7B | 55.7% | 10 |
| Current FY 2026-12-31 |
$1.07 | $0.63 | $1.38 | 163.5% | +10.8% | 8↑ 1↓ | $18.6B | 58.8% | 9 |
| Next FY 2027-12-31 |
$1.46 | $1.00 | $2.00 | 36.2% | +5.8% | 5↑ 3↓ | $19.8B | 6.8% | 10 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.333 | |
| 7d ago | $0.376 | -0.043 |
| 30d ago | $0.396 | -0.063 |
| 60d ago | $0.142 | +0.191 |
| 90d ago | $0.142 | +0.191 |
5 analyst firms have rated this stock: 4 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 10, 2026 | Barclays | UPGRADE | Equal-Weight | Overweight |
| May 26, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| May 7, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| May 7, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| May 7, 2026 | Baird | MAINTAIN | Neutral | Neutral |
| May 6, 2026 | Wolfe Research | INITIATE | — | Peer Perform |
| Apr 20, 2026 | Jefferies | UPGRADE | Underperform | Hold |
| Jan 9, 2026 | UBS | UPGRADE | Sell | Neutral |
| Jan 5, 2026 | Barclays | UPGRADE | Underweight | Equal-Weight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 6 | 9 | 2 | 0 | 42% | |
| May 1, 2026 | 2 | 6 | 8 | 2 | 0 | 44% | |
| Apr 1, 2026 | 0 | 3 | 8 | 3 | 3 | 18% | |
| Mar 1, 2026 | 0 | 3 | 8 | 3 | 3 | 18% | |
| Feb 1, 2026 | 0 | 2 | 8 | 4 | 3 | 12% | |
| Jan 1, 2026 | 0 | 2 | 6 | 5 | 3 | 13% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
63°
Warm
Bearish
Neutral
Bullish
4 mentions
2 bullish
0 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 29, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| Apr 29, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| Apr 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Jun 12, 2026
short_volume
Short Volume: OSCR — 57.6% short (1.6M / 2.8M)
Short: 1,592,131 | Exempt: 37,789 | TRF Vol: 2,764,797 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_interest
FTD: OSCR — 140,999 shares ($2.8M) failed to deliver
Settlement: 20260507, Price: $19.84, FTD Value: $2,797,420.16, OSCAR HEALTH INC CL A
May 6, 2026
earnings_calendar
OSCR Q1 2026 Earnings Scheduled — 2026-05-06
Apr 20, 2026
short_interest
FTD: OSCR — 36,282 shares ($0.6M) failed to deliver
Settlement: 20260420, Price: $15.79, FTD Value: $572,892.78, OSCAR HEALTH INC CL A